Ozempic Patent Expiry Set to Spark Cheaper Weight-Loss Drug Boom in India
The patent for semaglutide the key ingredient in Ozempic and Wegovy developed by Novo Nordisk is set to expire in…
Ajanta Pharma
Read More
March 17, 2026
- Ozempic Patent Expiry Set to Spark Cheaper Weight-Loss Drug Boom in India
- World Bank Approves $300 Million Loan for Uttar Pradesh’s Clean Air Transition
- AIIMS-Delhi Initiates India’s First Passive Euthanasia Process for Coma Patient
- West Asia Conflict Dampens Medical Tourism to India, Patient Inflow Drops Sharply